American International Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-32,509
| Closed | -$1.52M | – | 645 |
|
|
2024
Q1 | $1.52M | Buy |
32,509
+52
| +0.2% | +$2.43K | 0.01% | 1097 |
|
|
2023
Q4 | $1.15M | Buy |
32,457
+207
| +0.6% | +$7.37K | ﹤0.01% | 1234 |
|
|
2023
Q3 | $959K | Buy |
32,250
+6,585
| +26% | +$196K | 0.01% | 1256 |
|
|
2023
Q2 | $462K | Buy |
25,665
+266
| +1% | +$4.79K | ﹤0.01% | 1690 |
|
|
2023
Q1 | $408K | Buy |
25,399
+506
| +2% | +$8.13K | ﹤0.01% | 1712 |
|
|
2022
Q4 | $456K | Sell |
24,893
-91
| -0.4% | -$1.67K | ﹤0.01% | 1644 |
|
|
2022
Q3 | $491K | Buy |
24,984
+354
| +1% | +$6.96K | ﹤0.01% | 1587 |
|
|
2022
Q2 | $459K | Buy |
24,630
+1,749
| +8% | +$32.6K | ﹤0.01% | 1657 |
|
|
2022
Q1 | $502K | Sell |
22,881
-1,611
| -7% | -$35.3K | ﹤0.01% | 1724 |
|
|
2021
Q4 | $696K | Buy |
24,492
+4,013
| +20% | +$114K | ﹤0.01% | 1620 |
|
|
2021
Q3 | $431K | Buy |
20,479
+40
| +0.2% | +$842 | ﹤0.01% | 1962 |
|
|
2021
Q2 | $385 | Buy |
20,439
+4,668
| +30% | +$88 | ﹤0.01% | 2089 |
|
|
2021
Q1 | $241 | Buy |
15,771
+41
| +0.3% | +$1 | ﹤0.01% | 2273 |
|
|
2020
Q4 | $222 | Sell |
15,730
-451
| -3% | -$6 | ﹤0.01% | 2226 |
|
|
2020
Q3 | $254K | Sell |
16,181
-368
| -2% | -$5.78K | ﹤0.01% | 1992 |
|
|
2020
Q2 | $290K | Buy |
16,549
+10,012
| +153% | +$175K | ﹤0.01% | 1900 |
|
|
2020
Q1 | $96K | Sell |
6,537
-377
| -5% | -$5.54K | ﹤0.01% | 2328 |
|
|
2019
Q4 | $173K | Sell |
6,914
-58
| -0.8% | -$1.45K | ﹤0.01% | 2302 |
|
|
2019
Q3 | $105K | Sell |
6,972
-50
| -0.7% | -$753 | ﹤0.01% | 2574 |
|
|
2019
Q2 | $176K | Buy |
7,022
+1,544
| +28% | +$38.7K | ﹤0.01% | 2309 |
|
|
2019
Q1 | $125K | Buy |
5,478
+893
| +19% | +$20.4K | ﹤0.01% | 2492 |
|
|
2018
Q4 | $138K | Sell |
4,585
-35
| -0.8% | -$1.05K | ﹤0.01% | 2410 |
|
|
2018
Q3 | $132K | Buy |
+4,620
| New | +$132K | ﹤0.01% | 2672 |
|